Pilot Study Evaluating the efficacy and safety of Polymyxin B-immobilized Fiber Column (PMX) Hemoperfusion Treatment for Idiopathic Pulmonary Fibrosis with Acute Exacerbatio
Not Applicable
- Conditions
- Idiopathic pulmonary fibrosis
- Registration Number
- JPRN-UMIN000013116
- Lead Sponsor
- ippon Medical School Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) pregnant or lactating 2) history of hypersensitivity for blood purification or Extracorporeal circulation therapy 3) participated in another clinical research of non-approved medical device or drug , or has not passed the time of 5 times or more of the half-life in blood of a non-approved drug after the end of non-approved drug medication 4) difficulty in evaluation of this study; terminal cancer, chronic renal failure, the death within seven days are predicted 5) endotoxin blood symptom 6) respiratory infection, pneumothorax, pulmonary embolism, or heart failure 7) considered ineligible for the study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method